Healthcare Times Utah: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Times Utah.

Press releases published on November 5, 2026

Nov. 5, 2026

Grace Therapeutics Announces Participation in Upcoming Industry and Investor Events in November 2026

Indeterminate GlobeNewswire

Nov. 5, 2026

Incyclix Bio Establishes Steering Committee of Leading Breast Cancer Experts to Guide INX-315 Clinical Development

Indeterminate GlobeNewswire

Nov. 5, 2026

Arcutis Begins Enrolling Phase 3 Study Evaluating ZORYVE® (roflumilast) Cream 0.3% in Moderate to Severe Atopic Dermatitis

Indeterminate GlobeNewswire

Nov. 5, 2026

Nova Anchora Announces $23 Million Financing to Advance Topical Collagen VII Therapy for Dystrophic Epidermolysis Bullosa

Indeterminate GlobeNewswire

Nov. 5, 2026

Ovid Therapeutics to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Nov. 5, 2026

PharmAla Signs Agreement and Initiates R&D with Corealis Pharma for GMP Manufacturing of its patented ALA-002 Drug Product

Indeterminate GlobeNewswire

Nov. 5, 2026

Baird Medical and Alpmed Announce FDA 510(k) and EU CE Submissions for Irreversible Electroporation (IRE) System

Indeterminate GlobeNewswire

Nov. 5, 2026

Immutep Announces Upcoming Poster Presentations at CTOS 2026 and ESMO Immuno-Oncology & Advanced Therapies Congress 2026

Indeterminate GlobeNewswire

Nov. 5, 2026

Science 37 Named 2026 “BioTechnology Innovation of the Year” for its Direct-to-Patient Clinical Trial Delivery Model

Indeterminate GlobeNewswire

Nov. 5, 2026

Shattuck Labs Reports Third Quarter 2026 Financial Results and Recent Business Highlights

Indeterminate GlobeNewswire

Nov. 5, 2026

electroCore to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

Indeterminate GlobeNewswire

Nov. 5, 2026

Filana Therapeutics Reports Q3 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire

Nov. 5, 2026

BriaCell Awarded 2026 “Immunotherapy Solution of the Year” By BioTech Breakthrough

Indeterminate GlobeNewswire

Nov. 5, 2026

Scribe Therapeutics to Participate in Upcoming Healthcare Investor Conferences

Indeterminate GlobeNewswire

Nov. 5, 2026

Verrica Pharmaceuticals to Report Third Quarter 2026 Financial Results and Provide a Corporate Update on November 12, 2026

Indeterminate GlobeNewswire

Nov. 5, 2026

Altimmune to Report Third Quarter 2026 Financial Results and Provide Business Update on November 12, 2026

Indeterminate GlobeNewswire

Nov. 5, 2026

Belite Bio to Host Webcast on November 12, 2026, to Discuss Third Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Nov. 5, 2026

VeonGen Announces FDA Alignment on Pivotal Phase 3 Development and Clinical Progress of VG801 for Stargardt Disease

Indeterminate GlobeNewswire

Nov. 5, 2026

Solid Biosciences to Participate in the Guggenheim 3rd Annual Healthcare Innovation Conference

Indeterminate GlobeNewswire

Nov. 5, 2026

Sight Sciences Announces CMS Establishment of a Practice Expense Supply Code for TearCare SmartLids

Indeterminate GlobeNewswire